BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 21809268)

  • 1. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
    Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
    BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
    Gilligan TD; Seidenfeld J; Basch EM; Einhorn LH; Fancher T; Smith DC; Stephenson AJ; Vaughn DJ; Cosby R; Hayes DF;
    J Clin Oncol; 2010 Jul; 28(20):3388-404. PubMed ID: 20530278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of serum tumor markers during surveillance for stage I seminoma.
    Vesprini D; Chung P; Tolan S; Gospodarowicz M; Jewett M; O'Malley M; Sweet J; Moore M; Panzarella T; Sturgeon J; Sugar L; Anson-Cartwright L; Warde P
    Cancer; 2012 Nov; 118(21):5245-50. PubMed ID: 22517478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma.
    Koshida K; Uchibayashi T; Yamamoto H; Hirano K
    Br J Urol; 1996 Jan; 77(1):138-42. PubMed ID: 8653285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testis cancer markers. Clinical use].
    Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
    Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical symptoms in patients with germinal testicular tumors].
    Dieckmann KP; Krain J; Gottschalk W; Büttner P
    Urologe A; 1994 Jul; 33(4):325-30. PubMed ID: 7524231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
    Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
    Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
    Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
    Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.